Log In or Create Account

CROI
Conference on Bacteriophages
RWHAP Clinical Conference
Podcasts
Slides
Question of the Week
Donate
Contact

Advanced Search

CME Courses
CME Webinars
Dialogues
Topics In Antiviral Medicine
HIV Drug Resistance
Fellow Resources
About

Sara E. Looby, PhD, ANP-BC

Sara E. Looby, PhD, ANP-BC

Massachusetts General Hospital

Boston, MA

Harvard Medical School
Boston, MA

131 Steuart St, Suite 500, San Francisco, CA 94105

Phone: (415) 544-9400 | info@iasusa.org

Home
Activities
Resources
About
Contact
Login
Careers
Donate
Website Policies

© 2025 International Antiviral Society–USA. All Rights Reserved.

CROI
Conference on Bacteriophages
RWHAP Clinical Conference
Podcasts
Slides
Question of the Week
Donate
Contact
CME Courses
CME Webinars
Dialogues
Topics In Antiviral Medicine
HIV Drug Resistance
Fellow Resources
About

Practice Question of the Week

November 10, 2025: Drug-Drug Interactions in People With HIV Undergoing Solid Organ Transplantation

In a patient with HIV planning to undergo solid organ transplantation, which of the following antiretroviral therapy regimens should be changed prior to transplant?
- A. Bictegravir/tenofovir alafenamide/emtricitabine
- B. Darunavir/cobicistat/tenofovir alafenamide/emtricitabine
- C. Dolutegravir/rilpivirine
- D. Maraviroc/dolutegravir/lamivudine

Register for the Webinar

View Archived Questions